Carla Enrica Gallenga

InstitutionUniversity of Ferrara
AddressFerrara
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in Spetember 2020 and January 2021 and May 2021
    All Publications
    Bar chart showing 9 publications over 9 distinct years, with a maximum of 1 publications in 2011 and 2013 and 2014 and 2015 and 2016 and 2017 and 2018 and 2019 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gallenga CE, Agnifili L, D'Aloisio R, Brescia L, Toto L, Perri P. Virtual learning solutions in COVID-19 era: University Italian Ophthalmology department perspective. Eur J Ophthalmol. 2021 May 12; 11206721211015576. PMID: 33977779.
      Citations:    Fields:    
    2. Bellomo RG, Gallenga CE, Caraffa A, Tetè G, Ronconi G, Conti P. Anaphylaxis is a rare reaction in COVID-19 vaccination. J Biol Regul Homeost Agents. 2021 May-Jun; 35(3):839-842. PMID: 34105336.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    3. Conti P, Pregliasco FE, Calvisi V, Caraffa Al, Gallenga CE, Kritas SK, Ronconi G. Monoclonal antibody therapy in COVID-19. J Biol Regul Homeost Agents. 2021 Mar-Apr; 35(2):423-427. PMID: 33904269.
      Citations: 1     Fields:    Translation:HumansCells
    4. Conti P, Caraffa A, Gallenga CE, Kritas SK, Frydas I, Younes A, Di Emidio P, Tetè G, Pregliasco F, Ronconi G. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. J Biol Regul Homeost Agents. 2021 Jan-Feb; 35(1):1-4. PMID: 33377359.
      Citations: 37     Fields:    Translation:HumansAnimalsPHPublic Health
    5. Gallenga CE, Contini C, Tana M, D'Eliseo D, Giuliani AL, Di Virgilio F, Paglia S. How to classify the covid-19 phenotype: a response from "the first soldier in the first trench" in Lombardy, north-western Italy. J Biol Regul Homeost Agents. 2021 Jan-Feb; 35(1):379-383. PMID: 33525862.
      Citations:    Fields:    Translation:Humans
    6. Conti P, Caraffa A, Gallenga CE, Ross R, Kritas SK, Frydas I, Younes A, Ronconi G. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. J Biol Regul Homeost Agents. 2020 Nov-Dec; 34(6):1971-1975. PMID: 33016027.
      Citations: 30     Fields:    Translation:HumansCells
    7. Conti P, Caraffa A, Gallenga CE, Ross R, Kritas SK, Frydas I, Younes A, Di Emidio P, Ronconi G, Toniato E. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). J Biol Regul Homeost Agents. 2020 Sep-Oct,; 34(5):1623-1627. PMID: 32744052.
      Citations: 21     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    8. Conti P, Caraffa A, Tetè G, Gallenga CE, Ross R, Kritas SK, Frydas I, Younes A, Di Emidio P, Ronconi G. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. J Biol Regul Homeost Agents. 2020 Sep-Oct,; 34(5):1629-1632. PMID: 32945158.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    9. Ronconi G, Teté G, Kritas SK, Gallenga CE, Caraffa Al, Ross R, Conti P. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines. J Biol Regul Homeost Agents. 2020 May-June,; 34(3):767-773. PMID: 32476380.
      Citations: 27     Fields:    Translation:HumansCellsPHPublic Health
    10. Conti P, Gallenga CE, Tetè G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R, Kritas SK. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020 March-April,; 34(2):333-338. PMID: 32228825.
      Citations: 68     Fields:    Translation:HumansCellsPHPublic Health
    11. Kritas SK, Ronconi G, Caraffa A, Gallenga CE, Ross R, Conti P. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. J Biol Regul Homeost Agents. 2020 January-February,; 34(1):9-14. PMID: 32013309.
      Citations: 91     Fields:    
    Gallenga's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (65)
    Explore
    _
    Co-Authors (44)
    Explore
    _
    Similar People (60)
    Explore
    _